58% of Patients Affected by 2022 Mpox Outbreak Report Lasting Physical Symptoms
More than half of those diagnosed with mpox during the 2022 outbreak still had lingering physical effects 11 to 18 months later.
Tag: monkeypox
All
Latest
58% of Patients Affected by 2022 Mpox Outbreak Report Lasting Physical Symptoms
More than half of those diagnosed with mpox during the 2022 outbreak still had lingering physical effects 11 to 18 months later.
Read More
Tecovirimat Safe But Ineffective Against clade II mpox
The Study of Tecovirimat for Mpox (STOMP) began in September 2022 as part of the US whole-of-government response to the clade II mpox outbreak.
Read More
NIH Trial Halts After Smallpox Drug Fails to Show Benefit for Mpox
A clinical trial testing a smallpox antiviral for mpox was halted after interim findings showed no efficacy in reducing lesion resolution or pain in mild to moderate cases.
Read More
WHO Authorizes First Mpox Vaccine for Children Over Age 1
The WHO has granted Emergency Use Listing for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO and the first for children over age 1.
Read More
First US Case of Clade I Mpox Confirmed in California
The California Department of Public Health confirmed through laboratory testing the first known case of clade I mpox in the United States.
Read More
WHO Grants Emergency Use Listing to Mpox Diagnostic Test
The World Health Organization has granted Emergency Use Listing to a rapid PCR-based mpox test, enhancing access to point-of-care diagnostics.
Read More
Mpox Vaccine Safe and Effective in Adolescents, Interim Analysis Shows
The NIH clinical trial aims to address a knowledge gap on mpox vaccine use in adolescent populations.
Read More
Minimally-Invasive Blood Collection May Improve Public Health
Minimally-invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.
Read More
CRISPR-Based Test Reduces Mpox Detection Time to Under an Hour
Using gene editing proteins combined with nanopore sensing technology, new research shows that testing for pathogens could become faster and more accessible.
Read More
FDA Issues EUA for Mpox Test
Authorized to be used in professional point-of-care settings, the nucleic acid amplification test can detect mpox virus and deliver results in 25 minutes.
Read More
CDC Activates Emergency Operations Center for Monkeypox Response
The CDC has activated its Emergency Operations Center for monitoring and coordinating the emergency response to monkeypox.
Read More
Fact Check on Monkeypox Transmission
Monkeypox can be transmitted via respiratory droplets, but it is not an aerosolized or airborne transmission disease, according to a “Fact Check” published recently by Reuters Health.
Read More
Monkeypox in Maryland: Case Reported in Traveler
The CDC has reported a case of monkeypox discovered in Maryland. The case was reported in a US traveler returning to the US from Nigeria, according to the agency.
Read More
Over 200 People May Have Been Exposed to Monkeypox in the US
The CDC is monitoring more than 200 people for potential exposure to monkeypox after an individual who contracted the disease in Nigeria arrived at a Texas airport.
Read MoreCDC Investigates Monkeypox Case in Texas
The CDC is looking into a case of an unusual virus called monkeypox in a traveler coming from Nigeria, according to a report from CNN Health.
Read More
How Monkeypox Damages the Lungs
The monkeypox virus increased production of proteins involved in inflammation while decreasing production of proteins that keep lung tissue intact and lubricated.
Read More